with DM and their care providers can become partners in reducing the risk for cardiovascluar disease in this high- risk population. References [ADA] American Diabetes Association. 2004a. Aspirin therapy in diabetes. Diabetes Care, 27(Suppl 1):S72–3. [ADA] American Diabetes Association. 2004b. Smoking and diabetes. Diabetes Care, 27(Suppl 1):S74–5. Anderson RM. 1995. Patient empowerment and the traditional medical model: a case of irreconcilable differences? Diabetes Care, 18: 412–15. Anderson RM, Funnel MM, Butler PM, et al. 1995. Patient empowerment: results of a randomized controlled trial. Diabetes Care, 18:943–9. Avis NE, Smith KW, McKinlay JB. 1989. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? Am J Public Health, 17:1608–12. Bairey-Merz CN, Buse JB, Tuncer D, et al. 2002. Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. J Am Coll Cardiol, 40:1877–81. Crane JA. 1997. Patient comprehension of doctor-patient communication on discharge from the emergency department. J Emerg Med, 15:1–7. Davis TC, Fredrickson DD, Arnold CL, et al. 2001. Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics, 107:E17. Davis TC, Fredrickson DD, Bocchini C, et al. 2002. Improving vaccine risk/benefit communication with an immunization education package: a pilot study. Ambul Pediatr, 2:193–200. Davis TC, Williams MV, Marin E, et al. 2002. Health literacy and cancer communication. CA Cancer J Clin, 52:134–49. Edwards A, Unigwe S, Elwyn G, et al. 2004. Personalised risk communication for informed decision making about entering screening programs. Cochrane Protocol. Cochrane Library 1: Update Software. Oxford. Engberg M, Christensen B, Karlsmose B, et al. 2002. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract, 51:546–52. Gerrard M, Gibbons FX, Reis-Bergan M. 1999. The effect of risk communication on risk perceptions: the signficance of individual differences. Monogr Natl Cancer Inst, 25:94–100. Grant RW, Cagliero E, Dubey AK, et al. 2004. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med, 21:150–5. Greenfield S, Kaplan S, Ware JE. 1988. Patients’ participation in medical care: effects on blood-sugar control and quality of life in diabetes. J Gen Intern Med, 3:448–57. Hall LML, Jung RT, Leese GP. 2003. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ, 326: 251–2. Haynes RB, McDonald H, Garg AX, et al. 2005. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev, 2:CD000011. Heisler M, Bouknight RR, Hayward RA, et al. 2002. The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med, 17:243–52. Kinnersley P, Butler CC, Prout H, et al. 2004. Interventions before consultations for helping patients address their information needs. Cochrane Protocol. Cochrane Library 1: Update Software: Oxford. Communicating risk in type 2 diabetes Kreuter MW, Strecher VJ. 1995. Changing inaccurate perceptions of health risk: results from a randomized trial. Health Psychol, 14:56–63. Lee JD, Sankaranarayanan S, Manley SE, et al. 2004. 10-year absolute coronary artery disease risk using the UKPDS risk engine predicts higher than with the Framingham risk function. Diabetes, 53(Suppl 2):A49. Lipkus IM, Hollands JG. 1999. The visual communication of risk. Monogr Natl Cancer Inst, 25:149–63. Lowensteyn I, Joseph L, Levinton C, et al. 1998. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med, 27:730–7. Meigs JB, Singer DE, Sullivan LM, et al. 1997. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcomes Research Team. Am J Med, 102:38–47. Mooradian A. 2003. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med, 163:33–40. [NCEP] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285:2486–97. Nielsen-Bohlman L, Panzer AM, Kindig DA (eds). 2004. Health literacy: a prescription to end confusion. Report of the Committee on Health Literacy, Board of Neuroscience and Behavioral Health. Washington: The National Academies Pr. p 3–18. O’Connor PJ. 2003. Overcome clinical intertia to control systolic blood pressure. Arch Int Med, 163:2677–8. Phillips LS, Branch WT, Cook CB, et al. 2001. Clinical inertia. Ann Intern Med, 135:825–34. Pierce M, Ridout D, Harding D, et al. 2000. More good than harm: a randomized controlled trial of the effect of education about familial risk of diabetes on psychological outcomes. Br J Gen Pract, 50: 867–71. Rost K, Roter D. 1987. Predictors of recall of medication regimens and recommendations for lifestyle change in elderly patients. Gerontologist, 27:510–15. Roter DL. 2000. The outpatient medical encounter and elderly patients. Clin Geriatr Med, 16:95–107. Rothman AJ, Kiviniemi MT. 1999. Treating people with information: an analysis and review of approaches to communicating health risk information. Monogr Natl Cancer Inst, 25:44–51. Ruggiero L, Prochaska JO. 1993. Readiness for change: application of the transtheoretical model to diabetes. Diabetes Spectr, 6:22–60. Schillinger D, Grumbach K, Piette J, et al. 2002. Association of health literacy with diabetes outcomes. J Am Med Assoc, 288:475–82. Sheridan S, Pignone M, Mulrow C. 2003. Framingham-based tools to calcluate the global risk of coronary heart disease; a systematic review of tools for clinicians. J Gen Intern Med, 18:1039–52. Sowers JR, Haffner S. 2002. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension, 40:781–8. Strecher VJ, Greenwood T, Wang C, et al. 1999. Interactive mulitimedia and risk communication. Monogr Natl Cancer Inst, 25:134–9. [UKPDS] United Kingdom Prospective Diabetes Study Group. 1998. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352:837–53. [UKPDS] United Kingdom Prospective Diabetes Study Group. 2001. The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes (UKPDS 56). Clin Sci, 101:671–9. Vijan S, Hayward R. 2004. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med, 140:650–8. Vascular Health and Risk Management 2005:1(4) 307